blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3875595

EP3875595 - LIQUID MEDIUM PREPARATION METHOD [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  06.08.2021
Database last updated on 05.10.2024
FormerThe international publication has been made
Status updated on  09.05.2020
Most recent event   Tooltip05.10.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Kyowa Kirin Co., Ltd.
1-9-2, Otemachi
Chiyoda-ku
Tokyo 100-0004 / JP
[2021/36]
Inventor(s)01 / HIRA Shusuke
c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2,
Otemachi, Chiyoda-ku
Tokyo 100-0004 / JP
02 / SUZAWA Toshiyuki
c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2,
Otemachi, Chiyoda-ku
Tokyo 100-0004 / JP
 [2021/36]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2021/36]
Application number, filing date19878782.201.11.2019
[2021/36]
WO2019JP43031
Priority number, dateUS201862754793P02.11.2018         Original published format: US 201862754793 P
[2021/36]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020091041
Date:07.05.2020
Language:JA
[2020/19]
Type: A1 Application with search report 
No.:EP3875595
Date:08.09.2021
Language:EN
[2021/36]
Search report(s)International search report - published on:JP07.05.2020
(Supplementary) European search report - dispatched on:EP14.06.2022
ClassificationIPC:C12P21/08, C12N5/16, C12N1/00, C12N5/00, C12P21/02
[2022/28]
CPC:
C12N5/0018 (EP,US); C12P21/02 (EP,US); C12N2500/02 (EP,US);
C12N2500/10 (EP); C12N2500/20 (US); C12N2500/32 (EP,US)
Former IPC [2021/36]C12P21/08, C12N5/16, C12N1/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/36]
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINES FLÜSSIGEN MEDIUMS[2021/36]
English:LIQUID MEDIUM PREPARATION METHOD[2021/36]
French:PROCÉDÉ DE PRÉPARATION DE MILIEU DE CULTURE LIQUIDE[2021/36]
Entry into regional phase30.04.2021Translation filed 
30.04.2021National basic fee paid 
30.04.2021Search fee paid 
30.04.2021Designation fee(s) paid 
30.04.2021Examination fee paid 
Examination procedure30.04.2021Examination requested  [2021/36]
21.12.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
12.11.2021Renewal fee patent year 03
24.11.2022Renewal fee patent year 04
13.11.2023Renewal fee patent year 05
04.10.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XA]US2016289633  (YANG WILLIAM C [US], et al) [X] 14-17 * Sparging media with oxygen/air for CHO culture.; paragraphs [0072] - [0078] - [ 0171] - paragraph [0180]; example 1 *[A] 1-13;
 [XA]US2017356022  (KHAN MOHSAN WASEEM [GB], et al) [X] 14-17 * Prevention of formation of factors causing protein product dissociation.; paragraph [0173] - paragraphs [0182] , [ 0218] , [ 0231]; figure 1 * [A] 1-13;
 [XA]US10017732  (VIJAYASANKARAN NATARAJAN [US], et al) [X] 14-17 * Cell line antibody production.; paragraph [0190] - paragraph [0193]; examples 2, 3 * [A] 1-13
International search[XYA]WO2012091023  (KYOWA HAKKO KIRIN CO LTD [JP], et al) [X] 1-5, 7-8, 10, 14-27 * claims, paragraphs [0032], [0035] * [Y] 1-5, 7-8, 10, 14-33 [A] 6, 9, 11-13;
 [YA]JP2018068279  (LEK PHARMACEUTICALS DD) [Y] 1-5, 7-8, 10, 14-2 * (2018-05-10) paragraph [0004] * [A] 6, 9, 11-13;
 [A]  - MAYER, R. A. et al., "Preparation of media and buffers with soluble lead", Analytical Biochemistry, (20060000), vol. 356, doi:10.1016/j.ab.2006.02.032, pages 142 - 144, XP024942068 [A] 1-33 * , entire text *

DOI:   http://dx.doi.org/10.1016/j.ab.2006.02.032
by applicantJPH02227075
 JPH0322979
 JPH05336963
 WO9423021
 WO9630046
 WO9640201
 US5725856
 US5736137
 WO9851793
 US6855544
 WO2005017130
 WO2010008075
    - D. BRUHLMANN et al., Biotechnology Progress, (20150000), vol. 31, pages 615 - 629
    - T. KASCHAK et al., mAbs, (20110000), vol. 6, pages 577 - 583
    - R. J. HAY et al., Nature, (19890000), vol. 339, pages 487 - 488
    - The Journal of the American Medical Association, (19670000), vol. 199, page 519
    - Science, (19520000), vol. 122, page 501
    - Virology, (19590000), vol. 8, page 396
    - Proceeding of the Society for the Biological Medicine, (19500000), vol. 73, page 1
    - Proc. Natl. Acad. Sci. USA, (19650000), vol. 53, page 288
    - J. Experimental Medicine, (19780000), vol. 147, page 923
    - Journal of Experimental Medicine, (19580000), vol. 108, page 945
    - Proc. Natl. Acad. Sci. USA, (19680000), vol. 60, page 1275
    - Genetics, (19680000), vol. 55, page 513
    - Chromosoma, (19730000), vol. 41, page 129
    - Methods in Cell Science, (19960000), vol. 18, page 115
    - Radiation Research, (19970000), vol. 148, page 260
    - Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216
    - Proc. Natl. Acad. Sci., (19680000), vol. 60, page 1275
    - Cell, (19750000), vol. 6, page 121
    - Cytotechnology, (19900000), vol. 3, pages 133 - 900
    - Nature, (19870000), vol. 329, page 840
    - J. Biochem., (19870000), vol. 101, page 1307
    - Proc. Natl. Acad. Sci. USA, (19870000), vol. 84, page 7413
    - Virology, (19730000), vol. 52, page 456
    - J. Biol. Chem., (19770000), vol. 252, page 1998
    - Nature, (19940000), vol. 369, page 533
    - J. Biol. Chem., (19830000), vol. 258, page 9017
    - J. Exp. Med., (19920000), vol. 173, page 269
    - Science, (19760000), vol. 193, page 1007
    - J. Leuc. Biol., (19940000), vol. 55, page 280
    - Cancer Immunol. Immunother., (19930000), vol. 36, page 260
    - Cancer Res., (19940000), vol. 54, page 1511
    - Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 4285
    - British J. Cancer, (20000000), vol. 83, page 493
    - Molecular Immunol., (19990000), vol. 36, page 387
    - Cancer, (20000000), vol. 88, page 2909
    - LOWE et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, page 8227
    - J. Biol. Chem., (19900000), vol. 265, page 16455
    - J. Neurosci. Res., (19950000), vol. 40, page 647
    - J. Urology, (19980000), vol. 160, page 2396
    - Cancer Res., (19970000), vol. 57, page 4593
    - Oncogene, (20000000), vol. 19, page 2138
    - Curr. Opin. Oncol., (19980000), vol. 10, page 548
    - Cancer Res., vol. 55, no. 23, pages 5935s - 5945s
    - Immunol. Rev., (19920000), vol. 127, page 5
    - Molecular Immunol., (19940000), vol. 31, page 371
    - Cytokine, (19910000), vol. 3, page 562
    - J. Immunol. Methods, (19980000), vol. 217, page 41
    - Hybridoma, (19940000), vol. 13, page 183
    - Molecular Pharmacol., (20000000), vol. 58, page 237
    - Nature, (19990000), vol. 400, page 776
    - PERI et al., J. Immunol. Meth., (19940000), vol. 174, page 249
    - J. Exp. Med., (19970000), vol. 186, page 1373
    - J. Immunol., (19940000), vol. 152, page 2968
    - Science, (19910000), vol. 253, page 1129
    - J. Biol. Chem., (19970000), vol. 272, page 17400
    - Circulation, (20000000), vol. 101, page 1158
    - Structure, (20000000), vol. 8, page 385
    - J. Rheumatology, (19980000), vol. 25, page 2065
    - J. Clin. Microbiol., (19990000), vol. 37, page 396
    - PAULSON et al., J. Biol. Chem., (19890000), vol. 264, page 17619
    - Genes Develop., (19900000), vol. 4, page 1288
    - Tailoring Recombinant Protein Quality by Rational Media DesignBiotechnol. Prog., (20150000), vol. 31, no. 3, pages 615 - 629
 US19930627547
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.